


Healthcare News Roundup: Orthopaedic
HSMN NewsFeed - 25 Jan 2007
BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS(R)1 to Treat Distal Radius Fractures
BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS(R)1 to Treat Distal Radius Fractures
HSMN NewsFeed - 18 Jan 2007
Covalon Pursues the Orthopedic Market With Its Antimicrobial Coating on Orthopedic Implants
Covalon Pursues the Orthopedic Market With Its Antimicrobial Coating on Orthopedic Implants
HSMN NewsFeed - 17 Jan 2007
Aastrom Treats Patients in Adult Stem Cell Clinical Trial for Osteonecrosis
Aastrom Treats Patients in Adult Stem Cell Clinical Trial for Osteonecrosis
HSMN NewsFeed - 9 Jan 2007
RSB SPINE Announces Buy-Back of Right of First Refusal From NuVasive, Inc.
RSB SPINE Announces Buy-Back of Right of First Refusal From NuVasive, Inc.
HSMN NewsFeed - 5 Jan 2007
Spine Wave Board of Directors Adds Jerry Elliott, Chief Executive Officer of Global Signal
Spine Wave Board of Directors Adds Jerry Elliott, Chief Executive Officer of Global Signal
HSMN NewsFeed - 5 Jan 2007
Innovasis Announces Successful FDA Clearance for the 'PEEK Box' VBR System
Innovasis Announces Successful FDA Clearance for the 'PEEK Box' VBR System
HSMN NewsFeed - 3 Jan 2007
Kenney Joins Globus Medical as Vice President, Strategy and Corporate Development
Kenney Joins Globus Medical as Vice President, Strategy and Corporate Development
HSMN NewsFeed - 26 Dec 2006
Blackstone Medical Signs New Production Agreement With Regeneration Technologies, Inc.
Blackstone Medical Signs New Production Agreement With Regeneration Technologies, Inc.
HSMN NewsFeed - 21 Dec 2006
Kyphon Signs Definitive Agreements to Acquire All Spine-Related Assets of Disc-O-Tech Medical Technologies
Kyphon Signs Definitive Agreements to Acquire All Spine-Related Assets of Disc-O-Tech Medical Technologies
HSMN NewsFeed - 18 Dec 2006
Biomet, Inc. to Be Acquired by Private Equity Consortium for $10.9 Billion or $44 Per Share in Cash
Biomet, Inc. to Be Acquired by Private Equity Consortium for $10.9 Billion or $44 Per Share in Cash
HSMN NewsFeed - 13 Dec 2006
BioMimetic Therapeutics Announces Positive Results Using GEM OS1(TM) Bone Graft in Foot/Ankle Fusions
BioMimetic Therapeutics Announces Positive Results Using GEM OS1(TM) Bone Graft in Foot/Ankle Fusions
